These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38792257)
1. Novel 9-Methylanthracene Derivatives as p53 Activators for the Treatment of Glioblastoma Multiforme. Feng Y; Wang Y; Li X; Sun Z; Qiang S; Wang H; Liu Y Molecules; 2024 May; 29(10):. PubMed ID: 38792257 [TBL] [Abstract][Full Text] [Related]
2. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme. Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134 [TBL] [Abstract][Full Text] [Related]
3. XI-011 enhances cisplatin-induced apoptosis by functional restoration of p53 in head and neck cancer. Roh JL; Park JY; Kim EH Apoptosis; 2014 Nov; 19(11):1594-602. PubMed ID: 25113507 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
5. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma. Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758 [TBL] [Abstract][Full Text] [Related]
6. Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action. Punganuru SR; Artula V; Zhao W; Rajaei M; Deokar H; Zhang R; Buolamwini JK; Srivenugopal KS; Wang W Cells; 2020 Jul; 9(7):. PubMed ID: 32630235 [TBL] [Abstract][Full Text] [Related]
7. Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides. Yuan P; Gu X; Ni X; Qi Y; Shao X; Xu X; Liu J; Qian X Bioorg Med Chem Lett; 2021 Nov; 51():128371. PubMed ID: 34534673 [TBL] [Abstract][Full Text] [Related]
8. Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor. Costa B; Bendinelli S; Gabelloni P; Da Pozzo E; Daniele S; Scatena F; Vanacore R; Campiglia P; Bertamino A; Gomez-Monterrey I; Sorriento D; Del Giudice C; Iaccarino G; Novellino E; Martini C PLoS One; 2013; 8(8):e72281. PubMed ID: 23977270 [TBL] [Abstract][Full Text] [Related]
9. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation. Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461 [TBL] [Abstract][Full Text] [Related]
10. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro. Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341 [TBL] [Abstract][Full Text] [Related]
11. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition. Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Wang CL; Wang JY; Liu ZY; Ma XM; Wang XW; Jin H; Zhang XP; Fu D; Hou LJ; Lu YC Carcinogenesis; 2014 Jul; 35(7):1500-9. PubMed ID: 24445145 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Alonso M; Tamasdan C; Miller DC; Newcomb EW Mol Cancer Ther; 2003 Feb; 2(2):139-50. PubMed ID: 12589031 [TBL] [Abstract][Full Text] [Related]
14. Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis. Cao L; Qu D; Wang H; Zhang S; Jia C; Shi Z; Wang Z; Zhang J; Ma J Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869737 [TBL] [Abstract][Full Text] [Related]
15. Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle. Ren LW; Li W; Zheng XJ; Liu JY; Yang YH; Li S; Zhang S; Fu WQ; Xiao B; Wang JH; Du GH Acta Pharmacol Sin; 2022 Jan; 43(1):194-208. PubMed ID: 34433903 [TBL] [Abstract][Full Text] [Related]
17. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549 [TBL] [Abstract][Full Text] [Related]
18. Decane-1,2-diol derivatives as potential antitumor agents for the treatment of glioblastoma. Viswanathan A; Zhurina A; Assoah B; Paakkunainen A; Musa A; Kute D; Saravanan KM; Yli-Harja O; Candeias NR; Kandhavelu M Eur J Pharmacol; 2018 Oct; 837():105-116. PubMed ID: 30179612 [TBL] [Abstract][Full Text] [Related]